Beijing Strong Biotechnologies, Inc. (300406.SZ)
CNY 14.39
(0.7%)
CNY 14.39
(0.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.74 Billion | 1.51 Billion | 1.59 Billion | 848.11 Million | 840.86 Million | 774.17 Million |
| Cost of Revenue | 441.25 Million | 383.91 Million | 446.78 Million | 326.58 Million | 262.56 Million | 242.24 Million |
| Gross Profit | 1.3 Billion | 1.12 Billion | 1.15 Billion | 521.52 Million | 578.3 Million | 531.93 Million |
| Operating Expenses | 702.74 Million | 594.22 Million | 575.29 Million | 326.25 Million | 192.52 Million | 185.25 Million |
| Selling, General and Administrative Expenses | 499.28 Million | 379.72 Million | 373.28 Million | 218.18 Million | 112.2 Million | 109.92 Million |
| Research and Development Expenses | 162.89 Million | 137.19 Million | 127 Million | 79.05 Million | 70.31 Million | 61.03 Million |
| Other Expenses | 40.56 Million | -6.13 Million | 1.11 Million | -16.11 Million | 4.58 Million | 3.44 Million |
| Cost and Expenses | 1.14 Billion | 978.14 Million | 1.02 Billion | 652.84 Million | 455.08 Million | 427.49 Million |
| Operating Income | 593.87 Million | 455.48 Million | 535.87 Million | 153.04 Million | 377.75 Million | 347.27 Million |
| Interest Expense | 46.99 Million | 52.64 Million | 21.59 Million | 8.15 Million | 1.24 Million | 3.32 Million |
| Income Tax Expense | 71.48 Million | 54.85 Million | 67.33 Million | 15.24 Million | 50.25 Million | 49.28 Million |
| Earnings before Tax | 593.55 Million | 449.35 Million | 536.99 Million | 136.92 Million | 381.89 Million | 349.95 Million |
| Net Income | 523.74 Million | 389.09 Million | 405.65 Million | 112.27 Million | 331.64 Million | 300.66 Million |
| Earnings Per Share Basic | 0.90 | 0.66 | 0.69 | 0.21 | 0.66 | 0.57 |
| Earnings Per Share Diluted | 0.88 | 0.66 | 0.69 | 0.21 | 0.66 | 0.57 |
| Weighted Average Shares Outstanding | 581.93 Million | 588.84 Million | 587.9 Million | 534.65 Million | 501.78 Million | 527.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 595.16 Million | 588.84 Million | 587.9 Million | 534.65 Million | 501.78 Million | 527.48 Million |
| Gross Margin | 0.75 | 0.75 | 0.72 | 0.61 | 0.69 | 0.69 |
| EBIT Margin | 0.40 | 0.40 | 0.40 | 0.25 | 0.50 | 0.49 |
| Profit Margin | 0.30 | 0.26 | 0.25 | 0.13 | 0.39 | 0.39 |
| EBITDA | 697.99 Million | 556.81 Million | 604.56 Million | 178.28 Million | 405.15 Million | 371.03 Million |
| Earnings Before Tax Margin | 0.34 | 0.30 | 0.34 | 0.18 | 0.45 | 0.45 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 415.67 Million | 424.21 Million | 393.89 Million | 1.74 Billion | 507.94 Million | 417.35 Million |
| Cost of Revenue | 88.27 Million | 108.44 Million | 91.14 Million | 441.25 Million | 140.28 Million | 93.45 Million |
| Gross Profit | 327.39 Million | 315.77 Million | 302.75 Million | 1.3 Billion | 367.65 Million | 323.89 Million |
| Operating Expenses | 174.94 Million | 151.43 Million | 148.62 Million | 651.06 Million | 182.29 Million | 162.05 Million |
| Selling, General and Administrative Expenses | 235 Million | 111.67 Million | 103.79 Million | - | 57.01 Million | 163.55 Million |
| Research and Development Expenses | 42.56 Million | 39.75 Million | 42.88 Million | - | 52.98 Million | 35.09 Million |
| Other Expenses | -102.61 Million | -97.68 Thousand | -1.97 Million | -321.82 Thousand | -239.15 Thousand | 12.22 Thousand |
| Cost and Expenses | 263.22 Million | 259.87 Million | 239.76 Million | 1.09 Billion | 322.57 Million | 255.51 Million |
| Operating Income | 141.03 Million | 164.34 Million | 144.38 Million | 593.87 Million | 172.13 Million | 149.97 Million |
| Interest Expense | 12.06 Million | 11.58 Million | 11.79 Million | 46.99 Million | 11.8 Million | 11.67 Million |
| Income Tax Expense | 18.14 Million | 28.79 Million | 22.18 Million | 71.48 Million | 17.92 Million | 21.21 Million |
| Earnings before Tax | 140.95 Million | 158.16 Million | 142.4 Million | 593.55 Million | 171.89 Million | 149.98 Million |
| Net Income | 123.01 Million | 129.72 Million | 120.64 Million | 523.74 Million | 152.42 Million | 129.74 Million |
| Earnings Per Share Basic | 0.21 | 0.22 | 0.21 | - | 0.26 | 0.22 |
| Earnings Per Share Diluted | 0.21 | 0.22 | 0.21 | - | 0.26 | 0.22 |
| Weighted Average Shares Outstanding | 588.44 Million | 588.44 Million | 574.51 Million | 581.93 Million | 588.44 Million | 588.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 588.44 Million | 588.44 Million | 574.51 Million | 595.16 Million | 588.44 Million | 588.44 Million |
| Gross Margin | 0.79 | 0.74 | 0.77 | 0.75 | 0.72 | 0.78 |
| EBIT Margin | 0.37 | 0.43 | 0.39 | - | 0.40 | 0.39 |
| Profit Margin | 0.30 | 0.31 | 0.31 | 0.30 | 0.30 | 0.31 |
| EBITDA | 153.01 Million | 182.02 Million | 154.4 Million | - | 203.81 Million | 162.19 Million |
| Earnings Before Tax Margin | 0.34 | 0.39 | 0.37 | 0.34 | 0.34 | 0.36 |
APLUF
RHE
2942
5212
ALWEC
688090